Author: admin
Politicians & brands mark 4/20; MA gov signs marijuana bill; PA legalization; DE medical cannabis bill; Woody Harrelson & Bill Maher talk marijuana Subscribe to receive Marijuana Moment’s newsletter in your inbox every weekday morning. It’s the best way to make sure you know which cannabis stories are shaping the day. Your support makes Marijuana Moment possible… They say a journalist is a machine that converts coffee into copy. But where do you think the coffee comes from? Readers like you!Signing up for a $25/month subscription will help keep us digging, interviewing and reporting on all the cannabis news that’s fit…
The drug’s history of healing and experimentation stretches from ancient China to American counterculture — yet its promise remains trapped in a legal straitjacket. This article is adapted from The MIT Press Reader and reprinted with permission. It is adapted from Cannabinoids by Linda A. Parker, published by MIT Press. An altered state of consciousness, euphoria, relaxation, increased enjoyment of food tastes and aromas, distortion in time perception, joviality, introspection, and a heightened sense of creativity: These are some of the reported “psychoactive effects” often experienced by cannabis users, and they are the same effects that the drug has had…
Trump on psychedelics & marijuana rescheduling; New hemp bill lets states opt out of ban; TX cannabis poll; Study: Marijuana as sub for Rx drugs Subscribe to receive Marijuana Moment’s newsletter in your inbox every weekday morning. It’s the best way to make sure you know which cannabis stories are shaping the day. Your support makes Marijuana Moment possible… Free to read (but not free to produce)! We’re proud of our newsletter and the reporting we publish at Marijuana Moment, and we’re happy to provide it for free. But it takes a lot of work and resources to make this happen.…
By Eric Offenberger via Cannabis Confidential 69% of cannabis consumers have no brand preference. 18% say brand influences their purchase at all. The durable competitive moat in this business is not the brand on the package. It is the licensed retail door through which that package reaches the consumer. Editor’s note: Eric Offenberger is the CEO of Vext Science, a multi-state cannabis operator with dispensaries in Arizona and Ohio — which means he has a direct stake in the argument he’s making here. We’re republishing this piece from Cannabis Confidential because the argument is worth the industry’s attention, and because…
Every so often, a cannabis brand enters the market with a level of clarity that is immediately recognizable. Before the product is opened, before the effect is experienced, there is already a sense that the company understands exactly what it wants to communicate. In a category where many launches still feel experimental — as if brands are testing identity in real time — Boho Euphorics arrives in New Jersey with something more difficult to manufacture: confidence. That confidence becomes especially noticeable around 4/20, when the market tends to fill with louder promotions, limited releases, and seasonal attempts to capture attention.…
Scaling cannabis production isn’t just about output. It’s about process, consistency, and building systems that actually hold up under pressure. In cannabis, scaling sounds simple: grow more, produce more, sell more. For a while, that works. Then it doesn’t. Most operators don’t hit a ceiling because of demand or even product quality. They hit it because the systems behind their business weren’t built to handle growth. What worked at a small scale—hand-filled pre-rolls, manual packaging, patchwork workflows—starts to break under pressure. Production slows, consistency slips, and labor costs climb. At that point, the conversation usually turns to automation. But even that…
President Trump signed an executive order on April 18 directing the FDA to fast-track review of psychedelic therapies and committing $50 million to ibogaine research. The psychedelics community is cautiously optimistic, and watching closely. President Donald Trump signed an executive order on Saturday directing federal agencies to accelerate research into psychedelic therapies and committing $50 million through HHS to support state-backed psychedelic research, with ibogaine as the primary immediate beneficiary. The signing took place in the Oval Office on April 18, with Health and Human Services Secretary Robert F. Kennedy Jr., podcast host Joe Rogan, veterans advocate Marcus Luttrell and…
President Donald Trump used a White House press appearance on Saturday, April 18, to announce a new executive order aimed at accelerating federal research into psychedelic treatments for serious mental illness, with a specific focus on veterans living with PTSD and traumatic brain injuries. The announcement comes just ahead of 4/20 and signals a notable shift in how the federal government is approaching substances that have long remained restricted under Schedule I drug policy. Standing behind the president during the Oval Office remarks were Joe Rogan and Health and Human Services Secretary Robert F. Kennedy Jr., both of whom have…
As federal cannabis rescheduling looms on the horizon and more states across the country begin rolling out regulations for legal psychedelic therapy, health officials have increasingly been targeting a centuries-old psychoactive plant from Southeast Asia with newly introduced measures of prohibition. Kratom is a leafy green botanical native to Southeast Asia that acts on the opioid receptors and is noted for its ability to offer pain relief and euphoria to the more than 2 million Americans who are estimated to use it each year. It is this ancient plant medicine that is being increasingly scrutinized as a key issue in…
New bipartisan federal hemp bill soon; VA gov talks marijuana amendments; Cannabis arrest stories requested; “One Plant” cannabis strategy op-ed Subscribe to receive Marijuana Moment’s newsletter in your inbox every weekday morning. It’s the best way to make sure you know which cannabis stories are shaping the day. Your support makes Marijuana Moment possible… BREAKING: Journalism is often consumed for free, but costs money to produce! While this newsletter is proudly sent without cost to you, our ability to send it each day depends on the financial support of readers who can afford to give it. So if you’ve got a…